We are live on ! Find out more
AFJKR icon

Aimei Health Technology Right
AFJKR

13 hedge funds and large institutions have $1.46M invested in Aimei Health Technology Right in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% less funds holding

Funds holding: 15 → 13 (-2)

49% less capital inflows, than outflows

Capital inflows: $140K | Capital outflows: $276K

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

AFJKR Hedge Fund Activity: Q2 2025 in Review

13 of the 7,634 institutional investors tracked by Wall St. Rank reported a position in Aimei Health Technology Right (AFJKR) for Q2 2025, worth a combined $1.46M — down 33% from $2.19M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of AFJKR and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.

The largest buyer was Toronto Dominion Bank, adding an estimated $140K. The largest seller was Mangrove Partners, exiting entirely with an estimated $270K sold.

  • 13 institutional investors held Aimei Health Technology Right (AFJKR) as of Q2 2025, down from 15 in Q1 2025.
  • Funds reported $1.46M of Aimei Health Technology Right stock for Q2 2025, down 33% quarter-over-quarter.
  • 0 funds opened new Aimei Health Technology Right positions in Q2 2025 and 2 closed out, a net change of -2 holders.
  • The largest Aimei Health Technology Right buyer in Q2 2025 was Toronto Dominion Bank, an estimated $140K added.
  • The largest Aimei Health Technology Right seller in Q2 2025 was Mangrove Partners, an estimated $270K sold.

Based on aggregated 13F filings for Q2 2025.